Long acting risperidone cuts admissions
Risperidone long-acting injections can cut hospital admissions for people with schizophrenia, a UK study shows.
Records for 100 patients with schizophrenia who had completed 12 months on risperidone long-acting injections showed a significant reduction in hospital admissions - from 0.62 per person-year to 0.24.
The researchers said the reduction in hospital admissions was a good indicator of a lower chance of relapse – an important finding as 45% of patients in the study were switched to long-acting injections from other medications because of poor compliance.
Adherence to medication is known to be a key factor in relapse prevention, say the authors.